United Capital Financial Advisers LLC purchased a new stake in Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP – Get Rating) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 3,797 shares of the company’s stock, valued at approximately $271,000. United Capital Financial Advisers LLC owned about 0.09% of Invesco Dynamic Pharmaceuticals ETF at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in PJP. Credit Suisse AG bought a new position in shares of Invesco Dynamic Pharmaceuticals ETF in the 2nd quarter valued at about $58,000. FMR LLC grew its position in shares of Invesco Dynamic Pharmaceuticals ETF by 622.2% in the 2nd quarter. FMR LLC now owns 1,170 shares of the company’s stock valued at $88,000 after acquiring an additional 1,008 shares during the period. SeaCrest Wealth Management LLC bought a new position in shares of Invesco Dynamic Pharmaceuticals ETF in the 2nd quarter valued at about $100,000. Bank of Montreal Can grew its position in shares of Invesco Dynamic Pharmaceuticals ETF by 8.6% in the 1st quarter. Bank of Montreal Can now owns 2,359 shares of the company’s stock valued at $191,000 after acquiring an additional 187 shares during the period. Finally, Koshinski Asset Management Inc. bought a new position in shares of Invesco Dynamic Pharmaceuticals ETF in the 3rd quarter valued at about $218,000.
Invesco Dynamic Pharmaceuticals ETF Price Performance
Shares of PJP opened at $75.83 on Wednesday. The firm has a 50-day moving average of $78.22 and a 200-day moving average of $76.46. Invesco Dynamic Pharmaceuticals ETF has a one year low of $68.59 and a one year high of $84.11.
Invesco Dynamic Pharmaceuticals ETF Profile
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
Read More
- Get a free copy of the StockNews.com research report on Invesco Dynamic Pharmaceuticals ETF (PJP)
- Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
- Market Gets “Powelled”: S&P 500 Confirms Resistance
- Rivian Plummets, But Is This 2023’s Greatest Buying Opportunity?
- Ulta Insiders Hold Tight: Sell-Siders Buy
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP – Get Rating).
Receive News & Ratings for Invesco Dynamic Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
